|
Real-time Estimate
Cboe BZX
15:47:44 2026-11-09 EST
|
5-day change | 1st Jan Change | ||
| 9.955 USD | +10.61% |
|
+36.81% | -65.68% |
| 10-07 | Capricor Therapeutics, Inc. - Special Call | |
| 10-05 | Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data On Deramiocel For Upper Limb Function In Duchenne Muscular Dystrophy | CI |
| Market Cap | 523M 467M 430M 390M 739M 49.05B 758M 5.14B 2.05B 26.26B 1.96B 1.92B 82.7B | P/E 2026 * |
-4.99x | P/E 2027 * | -6.15x |
|---|---|---|---|---|---|
| Enterprise Value | 523M 467M 430M 390M 739M 49.05B 758M 5.14B 2.05B 26.26B 1.96B 1.92B 82.7B | EV / Sales 2026 * |
9.4x | EV / Sales 2027 * | 9.26x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CAPR | Delayed | |
CBOE
| CAPR | Real-time | |
|
Tradegate
| 4LN2 | Real-time | |
|
Boerse Muenchen
| 4LN2 | Real-time | |
|
Deutsche Boerse AG
| 4LN2 | Delayed | |
|
Xetra
| 4LN2 | Delayed | |
|
Börse Stuttgart
| 4LN2 | Delayed |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | +5.28% | ||
| 1 week | +30.39% | ||
| Current month | +47.96% | ||
| 1 month | +20.56% | ||
| 3 months | +145.19% | ||
| 6 months | -70.41% | ||
| Current year | -67.29% |
| 1 week | 7.15 |  | 9.48 |
| 1 month | 5.67 | | 9.48 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 2013-11-19 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 2017-12-31 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 2013-10-31 |
David Musket
BRD | Director/Board Member | 68 | 2013-11-19 |
George Dunbar
BRD | Director/Board Member | 79 | 2013-11-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/26/26 | Free | CHIEF COMMERCIAL OFFICER | 80,000 | 0.1383% | ||
| 5/18/26 | Exercice | Chief Financial Officer | 6,000 | 0.0104% | ||
| 5/13/26 | Exercice | Chairman | 7,874 | 0.0136% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.50% | +30.39% | +69.78% | +242.03% | 523M | |
| +2.24% | +5.83% | +58.47% | +65.65% | 66.7B | |
| +4.66% | +8.90% | +14.57% | +85.41% | 56.88B | |
| -0.60% | +1.73% | +23.48% | +94.40% | 56.53B | |
| +3.05% | +15.94% | +27.24% | +120.98% | 46.49B | |
| +2.56% | +8.01% | +31.02% | +45.46% | 44.8B | |
| +3.58% | +5.61% | +216.79% | +892.63% | 41.59B | |
| -0.47% | +9.60% | +27.53% | +52.88% | 35.35B | |
| +3.80% | -1.00% | +95.20% | +66.79% | 33.29B | |
| +0.66% | +5.69% | -39.81% | +393.27% | 25.1B | |
| Average | +2.54% | +7.07% | +52.43% | +205.95% | 40.72B | |
| Weighted average by Cap. | +2.32% | +4.01% | +51.34% | +180.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 55.69M 49.71M 45.74M 41.51M 78.67M 5.22B 80.62M 547M 218M 2.79B 209M 205M 8.8B | 56.54M 50.46M 46.44M 42.15M 79.87M 5.3B 81.85M 556M 221M 2.84B 212M 208M 8.94B |
| Net income | -130M -116M -107M -96.83M -184M -12.18B -188M -1.28B -509M -6.52B -488M -477M -20.53B | -87.96M -78.52M -72.25M -65.57M -124M -8.24B -127M -864M -344M -4.41B -330M -323M -13.9B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-09 | US$9.905 | +10.06% | 3,688,091 |
| 26-11-06 | US$9.000 | +4.65% | 4,664,303 |
| 26-11-05 | US$8.600 | -3.59% | 4,717,867 |
| 26-11-04 | US$8.920 | +8.25% | 6,439,133 |
| 26-11-03 | US$8.240 | +13.81% | 4,474,684 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
